Iodine uptake variability as a predictive biomarker for radioiodine therapy outcomes in Graves Disease: Validation through multi‐time‐point <scp>RAIU</scp> assessment in a 1249‐patient cohort
In this study, we proposed and defined IUV as a predictive biomarker for GD, and verified its impact on the prognosis of GD treated with RAI. Low IUV was associated with a poor clinical prognosis.
Authors
- Limeng Pan
- Sijie Yu
- Renming Li
- Wenbin Wang (ORCID: https://orcid.org/0000-0002-0582-8742)
- Yifan Li (ORCID: https://orcid.org/0009-0002-2507-3188)
- Meiwen He (ORCID: https://orcid.org/0000-0002-7290-1751)
- Nina Liu (ORCID: https://orcid.org/0000-0001-8293-877X)
- Zhenjie Hu (ORCID: https://orcid.org/0000-0003-1404-5691)
- Tianrong Pan (ORCID: https://orcid.org/0000-0002-4293-4579)
- Qiming Liu (ORCID: https://orcid.org/0000-0002-5826-2164)
- Hongjun Tian (ORCID: https://orcid.org/0000-0002-3919-3749)
Institutions
- Anhui Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1111/dom.16638
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00